320 related articles for article (PubMed ID: 29803721)
1. Influence of PLA-PEG nanoparticles manufacturing process on intestinal transporter PepT1 targeting and oxytocin transport.
Gourdon B; Chemin C; Moreau A; Arnauld T; Delbos JM; Péan JM; Declèves X
Eur J Pharm Biopharm; 2018 Aug; 129():122-133. PubMed ID: 29803721
[TBL] [Abstract][Full Text] [Related]
2. Functionalized PLA-PEG nanoparticles targeting intestinal transporter PepT1 for oral delivery of acyclovir.
Gourdon B; Chemin C; Moreau A; Arnauld T; Baumy P; Cisternino S; Péan JM; Declèves X
Int J Pharm; 2017 Aug; 529(1-2):357-370. PubMed ID: 28705621
[TBL] [Abstract][Full Text] [Related]
3. Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategy.
Du Y; Tian C; Wang M; Huang D; Wei W; Liu Y; Li L; Sun B; Kou L; Kan Q; Liu K; Luo C; Sun J; He Z
Drug Deliv; 2018 Nov; 25(1):1403-1413. PubMed ID: 29890854
[TBL] [Abstract][Full Text] [Related]
4. Double or Simple Emulsion Process to Encapsulate Hydrophilic Oxytocin Peptide in PLA-PEG Nanoparticles.
Gourdon B; Declèves X; Péan JM; Chemin C
Pharm Res; 2018 Mar; 35(4):82. PubMed ID: 29508092
[TBL] [Abstract][Full Text] [Related]
5. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
[TBL] [Abstract][Full Text] [Related]
6. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency.
Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X
Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400
[TBL] [Abstract][Full Text] [Related]
7. Design of PEG-grafted-PLA nanoparticles as oral permeability enhancer for P-gp substrate drug model Famotidine.
Mokhtar M; Gosselin P; Lacasse F; Hildgen P
J Microencapsul; 2017 Feb; 34(1):91-103. PubMed ID: 28151040
[TBL] [Abstract][Full Text] [Related]
8. Thiodipeptides targeting the intestinal oligopeptide transporter as a general approach to improving oral drug delivery.
Foley DW; Pathak RB; Phillips TR; Wilson GL; Bailey PD; Pieri M; Senan A; Meredith D
Eur J Med Chem; 2018 Aug; 156():180-189. PubMed ID: 30006163
[TBL] [Abstract][Full Text] [Related]
9. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
[TBL] [Abstract][Full Text] [Related]
10. Intestinal oligopeptide transporter PepT1-targeted polymeric micelles for further enhancing the oral absorption of water-insoluble agents.
Jin Y; Liu Q; Zhou C; Hu X; Wang L; Han S; Zhou Y; Liu Y
Nanoscale; 2019 Nov; 11(44):21433-21448. PubMed ID: 31681915
[TBL] [Abstract][Full Text] [Related]
11. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
12. Intestinal absorption and activation of decitabine amino acid ester prodrugs mediated by peptide transporter PEPT1 and enterocyte enzymes.
Tao W; Zhao D; Sun M; Wang Z; Lin B; Bao Y; Li Y; He Z; Sun Y; Sun J
Int J Pharm; 2018 Apr; 541(1-2):64-71. PubMed ID: 29471144
[TBL] [Abstract][Full Text] [Related]
13. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
[TBL] [Abstract][Full Text] [Related]
14. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
[TBL] [Abstract][Full Text] [Related]
15. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles.
Essa S; Rabanel JM; Hildgen P
Eur J Pharm Biopharm; 2010 Jun; 75(2):96-106. PubMed ID: 20211727
[TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of peptide transporter Pept1 gene in mice significantly reduces dipeptide absorption in intestine.
Hu Y; Smith DE; Ma K; Jappar D; Thomas W; Hillgren KM
Mol Pharm; 2008; 5(6):1122-30. PubMed ID: 19434858
[TBL] [Abstract][Full Text] [Related]
17. Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2.
Terada T; Sawada K; Saito H; Hashimoto Y; Inui K
Am J Physiol; 1999 Jun; 276(6):G1435-41. PubMed ID: 10362647
[TBL] [Abstract][Full Text] [Related]
18. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density.
Vila A; Gill H; McCallion O; Alonso MJ
J Control Release; 2004 Aug; 98(2):231-44. PubMed ID: 15262415
[TBL] [Abstract][Full Text] [Related]
19. Significance of peptide transporter 1 in the intestinal permeability of valacyclovir in wild-type and PepT1 knockout mice.
Yang B; Smith DE
Drug Metab Dispos; 2013 Mar; 41(3):608-14. PubMed ID: 23264448
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of antisense oligonucleotide functionalized core-shell nanoparticles loaded with α-tocopherol succinate.
Kilicay E; Karahaliloglu Z; Alpaslan P; Hazer B; Denkbas EB
J Biomater Sci Polym Ed; 2017 Oct; 28(15):1762-1785. PubMed ID: 28696185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
